CareDx, Inc.

For the period ended Apr 27, 2026. Filed Apr 27, 2026.

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Apr 27, 2026 · Filed Apr 27, 2026

CDNA$78.56+2.9%Stored close · as of Nov 6, 2026

See the whole filing, with its images and exhibits

Contents

Cover page

Show cover page

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE 14A

Proxy Statement Pursuant to Section 14(a) of the

Securities Exchange Act of 1934

Filed by the Registrant Filed by a Party other than the Registrant

Check the appropriate box:

☐	Preliminary Proxy Statement
☐	Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
☒	Definitive Proxy Statement
☐	Definitive Additional Materials
☐	Soliciting Material under §240.14a-12

(Name of Registrant as Specified In Its Charter)

(Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check all boxes that apply):

☒	No fee required.
☐	Fee paid previously with preliminary materials.
☐	Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

Message from the

Company’s Management

April 27, 2026

Dear CareDx Stockholder,

2025 was a year of strong execution for CareDx, as we advanced the long‑term strategy we outlined at our Investor Day

in October 2024.

Over the past year, we sharpened our focus, strengthened our operating foundation, and made deliberate investments to

support sustainable growth and long‑term value creation. Our progress reflects a disciplined approach to building a

durable, best‑in‑class financial profile while remaining firmly anchored to our mission to create life‑changing solutions that

enable transplant patients to thrive.

I am proud of what our team accomplished in 2025 and grateful for the continued confidence of our stockholders. We

remain focused on executing our strategy and advancing our vision of a world where every patient receives the care they

need to live longer, fuller lives.

Sincerely,

John W. Hanna | President and CEO

8000 Marina Boulevard, 4th Floor Brisbane, CA 94005

Notice of Annual Meeting

of Stockholders

Dear Stockholder:

You are cordially invited to attend the 2026 annual meeting of stockholders (the “Annual Meeting”) of CareDx, Inc., a Delaware

corporation (“CareDx,” “we”, “us”, “our”, or the “Company”). The Annual Meeting will be held on Thursday, June 11, 2026 at 10:00

a.m. Pacific Time, virtually via live webcast at http://www.virtualshareholdermeeting.com/CDNA2026.

Meeting Details

Date & TimeThursday, June 11, 2026 at 10:00 a.m. Pacific Time

LocationVirtually via live webcast at http://www.virtualshareholdermeeting.com/CDNA2026

Record DateApril 15, 2026

The Annual Meeting will be held for the following purposes, as more fully described in the accompanying proxy statement:

1	To elect five directors to serve until the 2027 annual meeting of stockholders or until their successors are duly elected and qualified;
2	To ratify the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for our fiscal year ending December 31, 2026;
3	To approve, on an advisory basis, the compensation of our named executive officers;
4	To approve, on an advisory basis, the frequency of advisory votes on the compensation of our named executive officers;
5	To approve an amendment to our 2024 Equity Incentive Plan to increase the available shares reserved thereunder; and
6	To conduct any other business properly brought before the Annual Meeting and any adjournments or postponements thereof.

Our Board of Directors has fixed the close of business on April 15, 2026 as the record date for the Annual Meeting. Only

stockholders of record on April 15, 2026 are entitled to notice of and to vote at the Annual Meeting. Further information regarding

voting rights and the matters to be voted upon are more fully described in the accompanying proxy statement.

On or about April 27,2026 we expect to mail our stockholders a Notice of Internet Availability of Proxy Materials (the “Notice”)

containing instructions on how to access our proxy statement and our annual report. The Notice provides instructions on how to

vote via the Internet or by telephone and includes instructions on how to receive a paper copy of our proxy materials by mail. The

accompanying proxy statement and our annual report can be accessed directly at http://investors.CareDxinc.com/financial-

information/annual-reports.

YOUR VOTE IS IMPORTANT. Whether or not you plan to attend the Annual Meeting, we urge you to submit your vote via

the Internet, telephone or mail as soon as possible so that your shares can be voted at the Annual Meeting in accordance

with your instructions.

Thank you for your continued support of CareDx.

By order of the Board of Directors,

/s/ Michael D. Goldberg

Chairman of the Board of Directors

Brisbane, California | April 27, 2026

Table of Contents

Proxy Statement for 2026 Annual Meeting of Stockholders	1
Questions and Answers about the Annual Meeting . . . . . . . .	1
Proposal No. 1 Election Of Directors . . . . . . . . . . . . . . . . . . . . .	9
Nominees . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	9
Vote Required; Board Recommendation . . . . . . . . . . . . . . . . .	9
Board of Directors and Corporate Governance . . . . . . . . . . .	10
Directors with Terms Expiring at the Annual Meeting-Nominees for Director . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	11
Continuing Directors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	16
Considerations in Evaluating Director Nominees . . . . . . . . . .	21
Director Independence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	21
Board Leadership Structure . . . . . . . . . . . . . . . . . . . . . . . . . . . .	22
Board Diversity of Skills and Expertise . . . . . . . . . . . . . . . . . . .	22
Legal Proceedings with Directors . . . . . . . . . . . . . . . . . . . . . . . .	23
Agreements with Directors . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	23
Board and Committee Meetings . . . . . . . . . . . . . . . . . . . . . . . . .	23
Compensation Committee Interlocks and Insider Participation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	26
Stockholder Recommendations for Nominations to the Board of Directors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	27
Communications with the Board of Directors . . . . . . . . . . . . . .	28
Corporate Governance Guidelines and Code of Business Conduct and Ethics . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	28
Clawback Policy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	28
Insider Trading Policy . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	29
Non-Employee Director Stock Ownership Policy . . . . . . . . . .	29
Executive Officer Stock Ownership Policy . . . . . . . . . . . . . . . .	29
Board of Directors’ Role in Risk Oversight . . . . . . . . . . . . . . . .	30
Director Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	31
Director Compensation Table . . . . . . . . . . . . . . . . . . . . . . . . . . .	32
Proposal No. 2 Ratification of Appointment of Independent Registered Public Accounting Firm . . . . . . . . .	34
Fees Paid to the Independent Registered Public Accounting Firm . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	34
Auditor Independence . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	35
Audit and Finance Committee Policy on Pre-Approval of Audit and Permissible Non-Audit Services of Independent Registered Public Accounting Firm . . . . . . . . . . . . . . . . . . . . . .	35
Vote Required; Board Recommendation . . . . . . . . . . . . . . . . .	35
Audit and Finance Committee Report . . . . . . . . . . . . . . . . . . . .	36
Proposal No. 3 Advisory Vote on Executive Compensation	37
Vote Required; Board Recommendation . . . . . . . . . . . . . . . . .	37
Proposal No. 4 Advisory Vote on Frequency of Advisory Votes on Executive Compensation . . . . . . . . . . . . . . . . . . . . . .	38
Vote Required; Board Recommendation . . . . . . . . . . . . . . . . .	38

Proposal No. 5 Approval of an Amendment to 2024 Equity Incentive Plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	39
Information on Equity Compensation Plans as of March 31, 2026 . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	40
Taking Action to Reduce Burn Rate and Dilution . . . . . . . . . .	40
Key Features and Governance Practices . . . . . . . . . . . . . . . . .	43
Summary of the 2024 Plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	44
Form S-8 Registration Statement . . . . . . . . . . . . . . . . . . . . . . . .	51
New Plan Benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	51
Federal Income Tax Consequences . . . . . . . . . . . . . . . . . . . . .	52
Vote Required; Board Recommendation . . . . . . . . . . . . . . . . .	54
Executive Officers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	55
Legal Proceedings with Executive Officers . . . . . . . . . . . . . . .	56
Executive Compensation . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	57
Compensation Discussion and Analysis . . . . . . . . . . . . . . . . . .	57
I. Executive Summary . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	57
II. Compensation Philosophy . . . . . . . . . . . . . . . . . . . . . . . . . . .	59
III. Compensation Determination Process . . . . . . . . . . . . . . . .	60
IV. Pay Components . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	62
Compensation and Human Capital Committee Report . . . . .	70
Summary Compensation Table . . . . . . . . . . . . . . . . . . . . . . . . .	71
Grants of Plan-Based Awards . . . . . . . . . . . . . . . . . . . . . . . . . .	73
Outstanding Equity Awards at Fiscal Year-End . . . . . . . . . . . .	74
Option Exercises and Stock Vested . . . . . . . . . . . . . . . . . . . . .	78
Pension Benefits . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	78
Pay Ratio Disclosure . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	82
Pay Versus Performance . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	83
Equity Compensation Plan Information . . . . . . . . . . . . . . . . . . .	87
Security Ownership of Certain Beneficial Owners and Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	88
Related Party Transactions . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	91
Indemnification Agreements . . . . . . . . . . . . . . . . . . . . . . . . . . . .	91
Rule 10b5-1 Sales Plans . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	91
Policies and Procedures for Related Party Transactions . . . .	91
Other Matters . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	92
Delinquent Section 16(a) Reports . . . . . . . . . . . . . . . . . . . . . . .	92
Available Information . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	92
Note About Forward-Looking Statements . . . . . . . . . . . . . . . . .	92
Householding . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	92
Company Website . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	93
Appendix A – 2024 Equity Incentive Plan (including Amendment No. 1) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	A-1
Appendix B – Amendment No. 2 to the 2024 Equity Incentive Plan . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .	B-1

CareDx Inc.	2026 Proxy Statement \| 1

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.